PatchSiren cyber security CVE debrief
CVE-2025-59853 HCL CVE debrief
CVE-2025-59853 Improper Error Handling vulnerability in HCL DFXAnalytics allows attackers to gain insights into application internal structure, code logic, and environment configurations. The vulnerability has a CVSS score of 3.1 and is considered LOW severity. HCL has provided a vendor advisory for this issue. Affected product deployments require verification, and defenders should assess exposure and prioritize verification of affected versions and application configurations to prevent potential information disclosure.
- Vendor
- HCL
- Product
- DFXAnalytics
- CVSS
- LOW 3.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-05-06
- Original CVE updated
- 2026-09-30
- Advisory published
- 2026-05-06
- Advisory updated
- 2026-09-30
Who should care
Defenders responsible for HCL DFXAnalytics deployments should assess exposure and prioritize verification of affected versions and application configurations to prevent potential information disclosure. This includes reviewing HCL DFXAnalytics versions, especially those prior to 4.1, and verifying vendor advisory for additional information.
Why it matters
CVE-2025-59853 is a LOW-severity vulnerability in HCL DFXAnalytics that requires verification of affected versions and configurations to prevent potential information disclosure.
- Potential information disclosure about application internal structure
- Possible insights into code logic and environment configurations
- Verification of HCL DFXAnalytics versions and configurations is necessary
Technical summary
The HCL DFXAnalytics application is vulnerable to an Improper Error Handling issue, which exposes detailed stack traces in responses. This could allow an attacker to gain insights into the application's internal structure, code logic, and environment configurations. The vulnerability has a CVSS score of 3.1 and is considered LOW severity. Defenders should assess exposure and prioritize verification of HCL DFXAnalytics versions, especially those prior to 4.1, and review application configurations to prevent information disclosure.
Defensive priority
Defenders should assess exposure and prioritize verification of HCL DFXAnalytics versions, especially those prior to 4.1, and review application configurations to prevent information disclosure.
Recommended defensive actions
- Assess exposure of HCL DFXAnalytics versions, especially those prior to 4.1
- Review application configurations to prevent information disclosure
- Verify vendor advisory for additional information
- Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up.
- Review compensating controls for exposed systems while remediation is scheduled and verified.
- Check relevant monitoring, detection, and logs for exposed assets that need extra review.
- Track exceptions, retest remediated assets, and close the item only after evidence is documented.
Evidence notes
The CVE record and NVD entry provide details on the vulnerability, including its CVSS score and affected versions. However, additional information on exploitation or impact is not available. Defenders should verify HCL DFXAnalytics versions, especially those prior to 4.1, and review application configurations to prevent information disclosure. The CVE Program and NVD provide official records and vulnerability assessments.
Sources and references
Verified primary and authoritative sources
-
CVE-2025-59853 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2025-59853
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2025-59853 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2025-59853
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.